Skip to main navigation

Targeted Medicine for the Ear

  • Home
  • Careers
  • Contact
Skip to content
  • About
    • Our Story
    • Executive Team
    • Board of Directors
  • Products
    • OTIPRIO®
  • Pipeline
    • Product Candidates
    • OTIVIDEX™
    • OTIPRIO®
    • OTO-313
    • Hearing Loss Programs
    • Clinical Trials
    • Expanded Access Policy
  • Otology
    • Otic Disorders
    • Otonomy Technology
    • Patient Organizations
  • Investors

    Investor Relations

    • OVERVIEW
    • Press Releases
    • Events and Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor FAQs
    • Contact Us

    Shareholder Tools

    • Print Page
    • RSS Feeds
    • Share Page
    • E-mail Alerts
  • News

Investor Relations

  • OVERVIEW
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Share Page
  • E-mail Alerts
X
  • Share on:
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Reddit
  • Digg
  • Google
  • Delicious
  • StumbleUpon

SEC Filing Details

Document Details

Form
SC 13G/A
Filing Date
Feb 8, 2019
Document Date
Feb 8, 2019
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
Otonomy Inc

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
©2019 Otonomy Inc.
  • Terms of Use
  • Privacy